Paul-Ehrlich-Institut's estimated revenue for 2024 is $46.4M.
What does Paul-Ehrlich-Institut do?
The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.
Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.
The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).
www.pei.de/impress
Pei has grown by 148.0% in the last 6 months according to SimilarWeb.
How do people interact with Pei?
Last month, Pei received 1M visitors who spent an average of 1.2 minutes on the website and visited 1.0 different pages per session. Overall, 78% of people bounce on the first visit.
How do people find Pei?
457.1k people (37%) visit Pei directly. 540.2k (44%) people search for them in Google. Whereas, 30.5k (2%) discover Pei through Facebook, Reddit, and YouTube. 6.5k (1%) visitors come from Pei's email newsletters. Finally, 395.7 (0.0%) people come from affiliates and or paid referrals.
Who uses Pei?
Pei's top market is the Germany and they receive 904.8k (73.4%) people.
Our clients trust us with $250m in paid advertising spend. we know what it takes to partner with you and get the results you need for your business to grow.... More